Prognostic utility of intact immunoglobulin Iga 2Io/Iga 2I ratios in multiple myeloma patients

Correspondence: Dr S Harding, Department of Research and Development, The Binding Site Group Limited, 8 Calthorpe Road, Birmingham B15 1QT, UK.

http://www.nature.com/leu/journal/v27/n1/full/leu2012159a.html